Table 1.
NO | Age | Sex | HBV | Blood Type | Primary Diagnosis | Initial IS Regiments |
---|---|---|---|---|---|---|
1 | 57 | M | + | A | HCC | T+My+S |
2 | 57 | M | + | O | HCC | T+My+S |
3 | 68 | M | + | O | HCC | T+My+S |
4 | 63 | M | + | B | Liver cirrhosis | T+My+S |
5 | 66 | F | + | O | Liver cirrhosis | T+My+S |
6 | 57 | M | + | O | HCC | T+My+S |
7 | 58 | M | + | A | HCC | T+My+S |
8 | 59 | M | + | A | HCC | T+My+S |
9 | 60 | M | + | B | Liver cirrhosis | T+My+S |
10 | 69 | F | + | O | Liver cirrhosis | T+My+S |
11 | 25 | M | – | A | / | / |
12 | 28 | F | – | B | / | / |
13 | 30 | M | – | A | / | / |
14 | 26 | M | – | O | / | / |
15 | 39 | M | – | O | / | / |
No. 1–5, patients with GVHD; No. 6–10, patients without GVHD; No. 11–15, Healthy volunteers; M, male; F, female; HCC, hepatocellular carcinoma; IS, immunosuppressive;
T, tacrolimus; My, mycophenolate mofetil; and S, steroids.